Dr. Jay Harness NBC News Interview: New Late-Stage Breast Cancer Treatment Option

Dr. Jay Harness comments on the promise of Halaven and other recent breast cancer treatment developments in an on-air interview hosted by CBS Los Angeles affiliate KNX NewsRadio.

The interview is available at this audio link.

Halaven is derived from a substance in a Japanese black sponge.

The U.S. Food and Drug Administration recently approved Halaven to treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease.

As reported in the Wall Street Journal:

Amid a dry spell for breakthrough cancer drugs, recent U.S. approval of Eisai Co.’s Halaven represents some vindication for a small group of researchers who believe, contrary to recent pharmaceutical fashion, that molecules from nature hold promise against hard-to-treat diseases.

According to Dr. Harness:

Through the evolution of the Earth, sea-based organisms have had to learn ways to protect themselves through specialized organic response substances.

One report says it well, “weapons of mass destruction are alive and well on a coral reef.”

It is these organic weapons which may be turned to human use to stop the growth of cancerous cells.

A drug such as Halaven demonstrates the potential benefits of continuing the hunt within nature for drugs of the future.

This entry was posted in Information Strength, News, Research News. Bookmark the permalink.

Comments are closed.